| __timestamp | Amneal Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 11032000 |
| Thursday, January 1, 2015 | 866280000 | 4050000 |
| Friday, January 1, 2016 | 1018225000 | 11043000 |
| Sunday, January 1, 2017 | 1033654000 | 327000 |
| Monday, January 1, 2018 | 1662991000 | 8198000 |
| Tuesday, January 1, 2019 | 1626373000 | 35219000 |
| Wednesday, January 1, 2020 | 1992523000 | 46551000 |
| Friday, January 1, 2021 | 2093669000 | 439442000 |
| Saturday, January 1, 2022 | 2212304000 | 722683000 |
| Sunday, January 1, 2023 | 2393607000 | 232284000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation have carved distinct paths over the past decade. From 2014 to 2023, Amneal's revenue surged by over 200%, showcasing its robust growth trajectory. In contrast, Dynavax, while starting from a modest base, experienced a remarkable revenue increase of over 6,400% by 2022, driven by strategic innovations and market expansions.
Amneal's consistent revenue growth, peaking at approximately $2.4 billion in 2023, underscores its strong market presence and operational efficiency. Meanwhile, Dynavax's revenue, which reached its zenith in 2022, highlights its potential in niche markets, particularly in vaccine development.
This revenue showdown not only reflects the dynamic nature of the biopharma industry but also emphasizes the diverse strategies companies employ to thrive in a competitive environment.
Breaking Down Revenue Trends: Eli Lilly and Company vs Dynavax Technologies Corporation
Breaking Down Revenue Trends: Novartis AG vs Dynavax Technologies Corporation
Bio-Techne Corporation vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Walgreens Boots Alliance, Inc. vs Dynavax Technologies Corporation
Ascendis Pharma A/S or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?
Amneal Pharmaceuticals, Inc. vs Mesoblast Limited: Examining Key Revenue Metrics
Arrowhead Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Dynavax Technologies Corporation vs Celldex Therapeutics, Inc.
Dynavax Technologies Corporation vs Evotec SE: Annual Revenue Growth Compared